MedTrace Logo

Use of Homeopathy in Patients Suffering From Long COVID-19

NCT06002230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-08-22

No results posted yet for this study

Summary

In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to Long-COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection.

Conditions

  • Adjustment Reaction With Physical Symptoms

Interventions

DRUG

Homeopathic medicines

Globules were administered orally..

Sponsors & Collaborators

  • Sigmund Freud PrivatUniversitat

    collaborator OTHER

  • Michael Frass

    lead OTHER

Principal Investigators

  • Michael Frass, MD · Institute for Homeopathic Research

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-05
Primary Completion
2021-10-19
Completion
2023-08-10

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002230 on ClinicalTrials.gov